A MULTI-CENTER RANDOMIZED TRIAL OF BUPRENORPHINE-NALOXONE VERSUS CLONIDINE FOR OPIOID DETOXIFICATION: FINDINGS FROM THE NATIONAL INSTITUTE ON DRUG ABUSE CLINICAL TRIALS NETWORK

Ähnliche Einträge

• PREDICTORS OF OUTCOME FOR SHORT-TERM MEDICALLY SUPERVISED OPIOID WITHDRAWAL DURING A RANDOMIZED, MULTICENTER TRIAL OF BUPRENORPHINE-NALOXONE AND CLONIDINE IN THE NIDA CLINICAL TRIALS NETWORK DRUG AND ALCOHOL DEPENDENCE
  von: ZIEDONIS, D.M
• Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial
  von: Hser, Y.I
• PAIN AND CONTINUED OPIOID USE IN INDIVIDUALS RECEIVING BUPRENORPHINE-NALOXONE FOR OPIOID DETOXIFICATION: SECONDARY ANALYSES FROM THE CLINICAL TRIALS NETWORK
  von: POTTER, J.S
• Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
  von: Hser, Y.I
• A RANDOMIZED TRIAL OF EFFECTIVENESS AND COST EFFECTIVENESS OF OBSERVED VERSUS UNOBSERVED ADMINISTRATION OF BUPRENORPHINE NALOXONE FOR HEROIN DEPENDENCE
  von: BELL, J.